Are transglutaminase 2 inhibitors able to decrease gliadin-induced toxicity related to coeliac disease? A proof-of-concept study
- Tiina Rauhavirta (Speaker)
- Kaukinen, K. (Speaker)
- Lindfors, K. (Speaker)
- Mäki, M. (Speaker)
Aktiviteetti: Konferenssiesitelmä